Clinicians and their patients with chronic kidney disease (CKD) need to be aware of zinc intake and anemia status.

Iron therapies, erythropoiesis stimulating agents (ESAs), and hypoxia inducible factor inhibitors (HIF-PHI) are used to treat anemia of chronic kidney disease (CKD).

Akebia Therapeutics Inc said on Thursday its experimental drug failed to meet the main safety goal in a late-stage trial testing the treatment in patients with anemia due to chronic kidney disease and ...

A proinflammatory diet might increase anemia risk in patients with diabetic kidney disease. Anemia occurs more frequently in patients with diabetic kidney disease (DKD) who have a proinflammatory diet ...

“Our launch of iron sucrose proves again that we remain committed to pioneering access to more affordable medicines for patients with chronic conditions,” said Keren Haruvi, President Sandoz North ...

PRINCETON, N.J., September 24, 2025--(BUSINESS WIRE)--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection ...

Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...

Modus Therapeutics will present new research on sevuparin for chronic kidney disease (CKD) with anemia at the 32nd Symposium on Glycosaminoglycans, held 18–20 September at Villa Vigoni, Italy. The ...

FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor signaling inhibitor (ASRI) and pre-chemotherapy ...

Learn about pet bloodwork, the tests involved, and how to interpret results to ensure your furry friend's health. Read the ...